Water soluble progesterone-hydroxypropyl-β-cyclodextrin complex for injectable formulations

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 283-288

  Zoppetti, G ^a   Puppini, N ^a   Pizzutti, M ^a   Fini, A ^b   Giovani, T ^c   Comini, S ^d  

^a IBSA SA   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^d Roquette Freres   (France)

Author keywords

Cyclodextrin; DSC; FTIR; Hydroxypropyl cyclodextrin; NMR; Phase solubility study; Progesterone; Raman; X ray

Indexed keywords

EID: 34047187407     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9174-2     Document Type: Conference Paper

References (7)

1. Pitha, J.: Pharmaceutical preparations containing cyclodextrin derivatives, US Patent n. 4,727,064.
2. Forgo, P., Gondos, G.: A study of b-Cyclodextrin Inclusion Complexes with Progesterone and HydrocorTisone Using Rotating Frame Over Hauser Spectroscopy. Monatyshefte fur cheme, 133, 101-106 (2002).
3. Kohyama, S.Z.N., Tsuruta, H.: Characterization of steroid/cyclodextrin inclusion compounds by x-ray powder diffractometry and thermal analysis. Ind. Health 34(2), 143-148 (1996).
4. Jeong, C.: Complexation of progesterone with cyclodextrins and design of aqueous parenteral formulations. J. Korean Pharm. Sci. 31(3), 151-160 (2001).
5. Martindale: The complete drug reference, 33rd edn, p. 1489 Pharmaceutical press, UK (2002).
6. Zoppetti, G., Puppini N., Pizzuti, M.: New injectable formulations containing progesterone, European Patent deposit n. 05108494.5.
7. Higuchi, T, Connors, K.A.: Phase-Solubility Techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965).